Global Morcellators Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Morcellators Market Size

• The global morcellators market size was valued at USD 142.86 million in 2024 and is expected to reach USD 254.80 million by 2032, at a CAGR of 7.50% during the forecast period
• The market growth is primarily driven by the rising prevalence of gynecological and urological disorders, along with the increasing preference for minimally invasive surgical procedures across healthcare systems worldwide
• In addition, technological advancements in morcellation devices—such as improved safety mechanisms and integrated visualization tools—are enhancing procedural efficiency and patient outcomes, which in turn is bolstering global demand. These combined factors are propelling the expansion of the morcellators market, positioning it as a critical component in modern laparoscopic surgeries

Morcellators Market Analysis

• Morcellators, used for fragmenting and removing large tissue masses during minimally invasive surgeries, are gaining traction in gynecological and laparoscopic procedures due to their ability to reduce surgical trauma, shorten recovery time, and enhance procedural efficiency in both hospital and outpatient settings
• The growing demand for morcellators is primarily driven by the global shift toward minimally invasive surgeries, rising incidences of uterine fibroids and other gynecological disorders, and advancements in device safety and design
• North America dominated the morcellators market with the largest revenue share of 40.5% in 2024, supported by the high volume of laparoscopic procedures, favorable reimbursement policies, and widespread adoption of advanced surgical tools, especially in the U.S. where regulatory approvals and technological innovation continue to drive growth
• Asia-Pacific is expected to be the fastest growing region in the morcellators market during the forecast period due to an expanding medical tourism sector, improving healthcare infrastructure, and rising awareness about minimally invasive procedures
• Electric Morcellator segment dominated the morcellators market with a market share of 50.5% in 2024, driven by its tissue dissection and widespread adoption in laparoscopic surgeries requiring rapid and precise tissue removal

Report Scope and Morcellators Market Segmentation

Morcellators Market Trends

“Advancements in Device Safety and Minimally Invasive Surgical Demand”

• A significant and accelerating trend in the global morcellators market is the advancement of safety-engineered morcellation devices designed to mitigate the risk of tissue dissemination during laparoscopic procedures such as hysterectomy and myomectomy. These innovations are increasingly aligning with evolving regulatory guidelines and clinical safety expectations
• For instance, newer morcellators integrated with containment systems, such as the Espiner tissue retrieval bag and Olympus's PK Morcellator with enhanced blade shielding, are gaining traction for their ability to confine tissue fragments within a sealed environment, reducing the risk of undiagnosed malignancy spread
• Electric morcellators are being developed with automation features to enhance procedural efficiency and precision, while disposable and reposable models are seeing increased demand due to their convenience, infection control benefits, and regulatory compliance
• Furthermore, leading manufacturers are investing in improved ergonomic designs and single-use innovations to facilitate surgeon ease and operational safety, making morcellators more compatible with modern laparoscopic techniques
• This shift toward safer, more user-friendly, and regulation-aligned devices is driving widespread adoption across hospitals and ambulatory surgical centers globally, particularly in regions emphasizing minimally invasive procedures
• The growing demand for advanced morcellators that integrate enhanced safety and performance features is rapidly expanding across gynecological and general surgical applications, with both developed and emerging markets contributing to growth.

Morcellators Market Dynamics

Driver

“Rising Demand for Minimally Invasive Surgeries and Uterine Fibroid Treatment”

• The global rise in minimally invasive surgical procedures, particularly for gynecological conditions such as uterine fibroids, is a key driver of the morcellators market. These procedures are favored due to shorter recovery times, minimal scarring, and lower hospitalization costs compared to traditional open surgeries
• For instance, laparoscopic hysterectomies and myomectomies utilizing morcellators are increasingly performed in outpatient and ambulatory settings, enhancing patient comfort and healthcare efficiency
• The prevalence of uterine fibroids, especially among women aged 30–50, is further propelling demand for morcellation-assisted procedures, encouraging hospitals to adopt advanced morcellation systems to improve clinical outcomes
• In addition, continuous product innovation by companies such as Karl Storz and Richard Wolf is contributing to better control, precision, and safety in morcellation, reinforcing its role in advanced surgical environments.

Restraint/Challenge

“Regulatory Scrutiny and Malignancy Dissemination Risk”

• A prominent challenge in the morcellators market is the heightened regulatory scrutiny due to concerns about potential dissemination of undiagnosed malignant tissue during morcellation, especially in gynecological surgeries
• For instance, following the U.S. FDA’s 2014 safety communication on laparoscopic power morcellators and their associated cancer spread risks, the market witnessed a temporary decline in device adoption and heightened demand for safer alternatives
• In response, regulatory agencies have emphasized the use of containment systems, robust clinical data, and product labeling revisions, placing additional development and compliance responsibilities on manufacturers
• Addressing these safety concerns through innovative containment technologies, comprehensive training, and strong clinical validation remains critical for rebuilding trust among healthcare providers and patients
• Furthermore, high procurement costs and inconsistent reimbursement policies, especially in cost-sensitive or developing markets, present additional barriers to the widespread deployment of advanced morcellator systems. Promoting affordability and evidence-based adoption will be essential to future market growth

Morcellators Market Scope

The market is segmented on the basis of type, application, usage type, and end use.

• By Type

On the basis of type, the morcellators market is segmented into electric morcellators, manual morcellators, and others. The electric morcellator segment accounted for the largest revenue share of 50.5% in 2024, driven by its superior efficiency, precision, and popularity in high-volume minimally invasive gynecological and general surgeries. These devices allow for faster tissue morcellation with reduced manual effort, making them ideal for use in complex laparoscopic procedures.

The manual morcellator segment is anticipated to register the fastest CAGR from 2025 to 2032, particularly in developing markets where cost-effectiveness and ease of use without reliance on electric power are critical. These devices are increasingly used in resource-constrained settings and in procedures with minimal tissue volume where electric morcellation is not necessary. The reduced risk of mechanical malfunction and lower maintenance cost further support their growing adoption.

• By Application

On the basis of application, the market is segmented into uterine fibroids, hysteroscopy, laparoscopy, and others. The uterine fibroids segment held the largest market share in 2024, attributed to the global prevalence of fibroids among women of reproductive age and the preference for minimally invasive myomectomy procedures.

The laparoscopy segment is projected to grow at the highest rate from 2025 to 2032, driven by the expanding use of laparoscopic techniques in general surgery, urology, and bariatrics. The demand for versatile morcellators that can be utilized across multiple laparoscopic interventions is increasing, especially as surgical techniques and technologies advance. The shift toward same-day surgeries and enhanced recovery protocols further accelerates growth in this segment.

• By Usage Type

On the basis of usage type, the market is segmented into reusable, reposable, and disposable morcellators. The reusable segment dominated the market in 2024 due to its widespread adoption in high-volume surgical centers that prioritize cost efficiency over time. These devices are engineered for durability and can be sterilized for repeated use, making them a cost-effective choice for hospitals with large surgical caseloads.

The disposable segment is expected to exhibit the fastest growth rate during the forecast period owing to rising concerns over cross-contamination, infection control, and the preference for sterile, single-use instruments. With increasing regulatory emphasis on patient safety and surgical hygiene, disposable morcellators are gaining favor in outpatient and ambulatory surgery settings

• By End Use

On the basis of end use, the market is segmented into hospitals, ambulatory surgical centers (ASCs), specialty clinics, and others. The hospitals segment held the largest revenue share in 2024 due to the availability of advanced surgical infrastructure, a wide range of procedural offerings, and higher patient throughput. Hospitals continue to be the leading adopters of electric and reusable morcellators, particularly for complex gynecological and general surgical cases.

The ambulatory surgical centers segment is anticipated to grow at the highest CAGR from 2025 to 2032, reflecting the shift toward outpatient surgical models and minimally invasive techniques. ASCs offer shorter turnaround times and cost advantages, making them ideal for procedures involving disposable or compact morcellator systems

Morcellators Market Regional Analysis

• North America dominated the morcellators market with the largest revenue share of 40.5% in 2024, supported by the high volume of laparoscopic procedures, favorable reimbursement policies, and widespread adoption of advanced surgical tools, especially in the U.S. where regulatory approvals and technological innovation continue to drive growth
• Hospitals and surgical centers in the region demonstrate a high utilization rate of electric morcellators due to their efficiency, safety features, and compliance with regulatory guidelines regarding tissue containment
• The market’s growth is further supported by favorable reimbursement policies, high healthcare spending, and the presence of leading manufacturers focused on innovation and product development, solidifying North America’s position as the primary hub for morcellator usage

U.S. Morcellators Market Insight

The U.S. morcellators market captured the largest revenue share of 79% in 2024 within North America, driven by a high volume of gynecological and laparoscopic procedures. The country’s well-established healthcare infrastructure, advanced surgical technologies, and focus on minimally invasive treatments contribute significantly to market dominance. Stringent FDA guidelines and widespread use of containment systems have also encouraged hospitals and surgical centers to adopt upgraded morcellator devices, especially electric variants with improved safety features.

Europe Morcellators Market Insight

The Europe morcellators market is projected to grow at a stable CAGR over the forecast period, supported by rising awareness of uterine fibroid treatments and increasing acceptance of minimally invasive surgeries. Government initiatives for women's health, coupled with the adoption of advanced laparoscopic tools, are enhancing market uptake. European healthcare systems emphasize patient safety, driving demand for reposable and disposable morcellators equipped with containment systems. The region’s focus on quality assurance and clinical outcomes supports consistent market growth.

U.K. Morcellators Market Insight

The U.K. morcellators market is anticipated to grow at a moderate CAGR during the forecast period, fueled by increasing demand for efficient gynecological surgeries and greater use of ambulatory surgical centers. Efforts to shorten hospital stays and improve recovery times have spurred the use of minimally invasive devices such as manual and reposable morcellators. Public sector investments in women’s health services and a strong focus on clinical safety protocols also contribute to market momentum across surgical and specialty clinics.  

Germany Morcellators Market Insight

The Germany morcellators market is expected to expand at a healthy CAGR during the forecast period, supported by the country's robust healthcare system and preference for technologically advanced surgical equipment. Hospitals and specialty clinics are increasingly adopting electric morcellators to optimize procedural efficiency and reduce tissue trauma. Germany’s emphasis on precision, innovation, and compliance with EU safety regulations ensures a strong demand for high-quality, reusable and disposable morcellation devices.

Asia-Pacific Morcellators Market Insight

The Asia-Pacific morcellators market is expected to register the fastest CAGR during the forecast period from 2025 to 2032, driven by rising surgical volumes, growing awareness of uterine health, and improving healthcare infrastructure. Countries such as China, India, and Japan are witnessing a surge in laparoscopic procedures due to greater availability of trained professionals and expanding access to advanced surgical technologies. The increasing focus on cost-effective and minimally invasive procedures is also spurring demand for both manual and reposable morcellators.

Japan Morcellators Market Insight

The Japan morcellators market is gaining traction owing to the country’s advanced medical technology landscape and growing adoption of laparoscopic surgeries. With a strong preference for precision instruments, hospitals and surgical centers in Japan are increasingly investing in electric and reusable morcellators. An aging population and heightened focus on women’s reproductive health are further propelling market growth, particularly in urban healthcare settings equipped with state-of-the-art surgical infrastructure.

India Morcellators Market Insight

The India morcellators market accounted for the largest revenue share in Asia-Pacific in 2024, driven by the country’s rising healthcare investments, large patient pool, and increasing demand for minimally invasive procedures. Rapid urbanization and growth in private hospitals and ambulatory surgical centers are creating robust demand for affordable, efficient morcellation solutions. Local manufacturing, government support for health infrastructure, and expanding gynecological care in Tier 2 and Tier 3 cities are further driving market development.

Morcellators Market Share

The morcellators industry is primarily led by well-established companies, including:

• Olympus Corporation (Japan)
• Karl Storz SE & Co. KG (Germany)
• Richard Wolf GmbH (Germany)
• LiNA Medical ApS (Denmark)
• Johnson & Johnson Services, Inc. (U.S.)
• Nouvag AG (Switzerland)
• Medtronic (Ireland)
• CooperSurgical, Inc. (U.S.)
• Lumenis Be Ltd. (Israel)
• B. Braun SE (Germany)
• Smith + Nephew (U.K.)
• Stryker (U.S.)
• Storz Medical AG (Switzerland)
• Hologic, Inc. (U.S.)
• Ackermann Instrumente GmbH (Germany)
• WISAP Medical Technology GmbH (Germany)
• BOWA-electronic GmbH & Co. KG (Germany)
• RUDOLF Medical GmbH + Co. KG (Germany)
• Karl Kaps GmbH & Co. KG (Germany)

What are the Recent Developments in Global Morcellators Market?

• In April 2023, Olympus Corporation, a global leader in medical technology, announced the launch of a next-generation laparoscopic morcellation system designed to enhance tissue extraction safety during minimally invasive gynecological procedures. The device features improved containment capabilities and ergonomic design, addressing long-standing safety concerns. This development underscores Olympus’s continued investment in innovation and patient safety, while reinforcing its leadership in the global morcellators market
• In March 2023, Karl Storz SE & Co. KG introduced a modular electric morcellator system optimized for reusable applications in laparoscopic surgeries. The new solution emphasizes operational efficiency, durability, and cost-effectiveness in surgical centers worldwide. Karl Storz’s innovation demonstrates its commitment to developing sustainable and high-performance devices, in line with growing hospital demands for eco-conscious and budget-friendly surgical equipment
• In March 2023, Richard Wolf GmbH partnered with several academic hospitals in Europe to initiate clinical trials evaluating its advanced containment-enabled morcellation system. The trial aims to validate improvements in surgical safety and patient outcomes in myomectomy and hysterectomy procedures. This initiative highlights the company's dedication to evidence-based product development and reinforces its focus on regulatory compliance and clinical effectiveness in the evolving morcellators market
• In February 2023, LiNA Medical USA launched its enhanced manual morcellator for ambulatory and outpatient procedures, designed with single-use efficiency and compact handling in mind. The device caters to clinics seeking streamlined surgical workflows and reduced cross-contamination risk. This launch reflects LiNA Medical’s strategic focus on providing affordable, disposable solutions that meet the needs of decentralized healthcare environments
• In January 2023, Xcelens Inc., a rising player in surgical instruments, unveiled a hybrid morcellator system combining electric power with containment integration, targeting U.S. and Latin American markets. The device aims to bridge the gap between safety compliance and cost efficiency, offering hospitals a flexible solution for fibroid and tissue removal procedures. Xcelens' entry into the morcellators segment marks a significant step in diversifying the competitive landscape and meeting the evolving demands of global surgical care

SKU-53282